Serum selenium and skin diseases among Nigerians with human immunodeficiency virus/acquired immune deficiency syndrome

HIV/AIDS - Research and Palliative Care

Volumn 5, Issue , 2013, Pages 215-221

  Akinboro, Adeolu Oladayo ^a   Mejiuni, David Ayodele ^b   Onayemi, Olaniyi ^c   Ayodele, Olugbenga Edward ^d   Atiba, Adeniran Samuel ^e   Bamimore, Gbenga Micheal ^d  

^a LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b Bullsbrook Medical Practice   (Australia)

^c OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^d Lautech Teaching Hospital   (Nigeria)

^e EKITI STATE UNIVERSITY   (Nigeria)

Author keywords

HIV AIDS; Nigeria; Osogbo; Serum selenium; Skin disease

Indexed keywords

SELENIUM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD ANALYSIS; BLOOD LEVEL; BODY MASS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FEVER; HAIR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NAIL DISEASE; NIGERIA; PALLOR; PAPULE; PRURITUS; SKIN DISEASE; THRUSH; VENOUS BLOOD; WEIGHT REDUCTION; XERODERMA;

EID: 84882795216     PISSN: None     EISSN: 11791373     Source Type: Journal    
DOI: 10.2147/HIV.S46364     Document Type: Article

References (36)

1. Nazi{dotless}roǧlu M, Yi{dotless}ldi{dotless}z K, Tamtürk B, Erturan İ, Flores-Arce M. Selenium and psoriasis. Biol Trace Elem Res. 2012;150(1-3):3-9.
2. Luty-Frackiewicz A. The role of selenium in cancer and viral infection prevention. Int J Occup Med Environ Health. 2005;18(4):305-311.
3. Gill H, Walker G. Selenium, immune function and resistance to viral infections. Nutr Diet. 2008;65(Suppl 3):S41-S47.
4. Rayman MP. The importance of selenium to human health. Lancet. 2000;356(9225):233-241.
5. Azu OO. Highly active antiretroviral therapy (HAART) and testicular morphology: current status and a case for a stereologic approach. J Androl. 2012;33(6):1130-1142.
6. Cedeno-Laurent F, Gómez-Flores M, Mendez N, etal. New insights into HIV-1-primary skin disorders. J Int AIDS Soc. 2011;14:5.
7. Baum MK, Shor-Posner G, Lai S, etal. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15(5):370-374.
8. Shor-Posner G, Miguez MJ, Pineda LM, etal. Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;29(2):169-173.
9. Yousefi M, Rahimi H, Barikbin B, etal. Uric Acid: a new antioxidant in patients with pemphigus vulgaris. Indian J Dermatol. 2011;56(3): 278-281.
10. DeSilva B, Beckett GJ, McLean S, Arthur JR, Hunter JA, Norval M, McKenzie RC. Lack of effect of oral selenite on p53 associated gene expression during TL01 therapy of psoriasis patients. Photodermatol Photoimmunol Photomed. 2007;23(2-3): 98-100.
11. Kadry D, Rashed L. Plasma and tissue osteopontin in relation to plasma selenium in patients with psoriasis. J Eur Acad Dermatol Venereol. 2012;26(1):66-70.
12. Song H, Kim J, Lee HK, etal. Selenium inhibits migration of murine melanoma cells via down-modulation of IL-18 expression. Int Immunopharmacol. 2011;11(12):2208-2213.
13. Serwin AB, Waşowicz W, Gromadzińska J, Chodynicka B. Selenium status in psoriasis and its relationship with alcohol consumption. Biol Trace Elem Res. 2002;89(2):127-137.
14. Arican O, Ozturk P, Kurutas EB, Unsal V. Status of oxidative stress on lesional skin surface of plantar warts. J Eur Acad Dermatol Venereol. 2012.
15. Ozturk P, Arican O, Kurutas EB, Karakas T, Gungor M. Local oxidative stress in interdigital tinea pedis. J Dermatol. 2013;40(2):114-117.
16. Maurer TA. Dermatologic manifestations of HIV infection. Top HIV Med. 2005-2006;13(5):149-154.
17. Drain PK, Baeten JM, Overbaugh J, etal. Low serum albumin and the acute phase response predict low serum selenium in HIV-1 infected women. BMC Infect Dis. 2006;6:85.
18. Hettiaratchy S, Papini R. Initial management of a major burn: II-assessment and resuscitation. BMJ. 2004;329(7457):101-103.
19. Paschal DC, Kimberly MM. Automated direct determination of selenium in serum by electrothermal atomic absorption spectroscopy. At Spectrosc. 1986;7:75-78.
20. Oster O, Prellwitz W. A methodological comparison of hydride and carbon furnace atomic absorption spectroscopy for the determination of selenium in serum. Clin Chim Acta. 1982;124(3):277-291.
21. Nnoruka EN, Chukwuka JC, Anisuiba B. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression. Int J Dermatol. 2007;46 Suppl 2:14-18.
22. Resneck JS, Van Beek M, Furmanski L, etal. Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA. 2004;292(21): 2614-2621.
23. Annam V, Yelikar BR, Inamadar AC, Palit A. Histopathological study of pruritic papular eruptions in HIV-infected patients in relationship with CD4, CD8 counts. Indian J Pathol Microbiol. 2009;52(3):321-324.
24. Namakoola I, Wakeham K, Parkes-Ratanshi R, etal. Use of nail and oral pigmentation to determine ART eligibility among HIV-infected Ugandan adults. Trop Med Int Health. 2010;15(2):259-262.
25. Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Interact. 1994;(9):181-186.
26. Sweeney MP, Bagg J, Fell GS, Yip B. The relationship between micronutrient depletion and oral health in geriatrics. J Oral Pathol Med. 1994;23(4):168-171.
27. Look MP, Rockstroh JK, Rao GS, Kreuzer KA, Spengler U, Sauerbruch T. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res. 1997;56(1): 31-41.
28. Becker Y. The spreading of HIV-1infection in the human organism is caused by fractalkine trafficking of the infected lymphocytes-a review, hypothesis and implications for treatment. Virus Genes. 2007;34(2): 93-109.
29. Ahmed Z, Czubala M, Blanchet F, Piguet V. HIV impairment of immune responses in dendritic cells. Adv Exp Med Biol. 2013;762:201-238.
30. Morgan D, Mahe C, Mayanja B, Whitworth JA. Progression to symptomatic disease in people infected with HIV-1in rural Uganda: prospective cohort study. BMJ. 2002;324(7331):193-196.
31. Josephine M, Issac E, George A, Ngole M, Albert SE. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon. Int J Dermatol. 2006;45(3):280-284.
32. Jensen BL, Weismann K, Sindrup JH, Søndergaard J, Schmidt K. Incidence and prognostic significance of skin disease in patients with HIV/AIDS: a 5-year observational study. Acta Derm Venereol. 2000;80(2):140-143.
33. Takata Y, King IB, Lampe JW, etal. Genetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans. J Nutr. 2012;142(3):419-426.
34. Reszka E, Jablonska E, Gromadzinska J, Wasowicz W. Relevance of selenoprotein transcripts for selenium status in humans. Genes Nutr. 2012;7(2):127-137.
35. Waters DJ, Chiang EC, Cooley DM, Morris JS. Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women. Mutat Res. 2004;551(1-2):91-107.
36. Geybels MS, Hutter CM, Kwon EM, etal. Variation in selenoenzyme genes and prostate cancer risk and survival. Prostate. 2013;73(7): 734-742.